2,3-diacetamido-2,3-dideoxy-glucuronic acid: acidic amino sugar from Pseudomonas aeruginosa type O6 lipopolysaccharide [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 196126 |
| SCHEMBL ID | 7153508 |
| MeSH ID | M0098976 |
| Synonym |
|---|
| 79319-92-9 |
| dadoga |
| (2s,3s,4r,5r)-4,5-diacetamido-2,3-dihydroxy-6-oxohexanoic acid |
| SCHEMBL7153508 |
| 2,3-diacetamido-2,3-dideoxy-glucuronic acid |
| d-glucuronic acid, 2,3-bis(acetylamino)-2,3-dideoxy- |
| 2,3-diacetamido-2,3-dideoxy-d-glucuronic acid |
| 2,3-dideoxy-2,3-bis{[(1-hydroxyethylidene)amino]}hexuronic acid |
| DTXSID801000394 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 3 (42.86) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (13.13) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 7 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||